Expression of podocyte-associated molecules in acquired human kidney diseases.

Proteinuria is a poorly understood feature of many acquired renal diseases. Recent studies concerning congenital nephrotic syndromes and findings in genetically modified mice have demonstrated that podocyte molecules make a pivotal contribution to the maintenance of the selective filtration barrier of the normal glomerulus. However, it is unclear what role podocyte molecules play in proteinuria of acquired renal diseases. This study investigated the mRNA and protein expression of several podocyte-associated molecules in acquired renal diseases. Forty-eight patients with various renal diseases were studied, including minimal change nephropathy, focal segmental glomerulosclerosis, IgA nephropathy, lupus nephritis, and diabetic nephropathy, together with 13 kidneys with normal glomerular function. Protein levels of nephrin, podocin, CD2-associated protein, and podocalyxin were investigated using quantitative immunohistochemical assays. Real-time PCR was used to determine the mRNA levels of nephrin, podocin, and podoplanin in microdissected glomeruli. The obtained molecular data were related to electron microscopic ultrastructural changes, in particular foot process width, and to clinical parameters. In most acquired renal diseases, except in IgA nephropathy, a marked reduction was observed at the protein levels of nephrin, podocin, and podocalyxin, whereas an increase of the glomerular mRNA levels of nephrin, podocin, and podoplanin was found, compared with controls. The mean width of the podocyte foot processes was inversely correlated with the protein levels of nephrin (r = -0.443, P < 0.05), whereas it was positively correlated with podoplanin mRNA levels (r = 0.468, P < 0.05) and proteinuria (r = 0.585, P = 0.001). In the diseases studied, the decrease of slit diaphragm proteins was related to the effacement of foot processes and coincided with a rise of the levels of the corresponding mRNA transcripts. This suggests that the alterations in the expression of podocyte-associated molecules represent a compensatory reaction of the podocyte that results from damage associated with proteinuria.

[1]  H. Holthöfer,et al.  Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition , 2002, Diabetologia.

[2]  G. Remuzzi,et al.  Podocyte number in normotensive type 1 diabetic patients with albuminuria. , 2002, Diabetes.

[3]  H. Holthöfer,et al.  Podocyte-Associated Molecules in Puromycin Aminonucleoside Nephrosis of the Rat , 2002, Laboratory Investigation.

[4]  G. Jerums,et al.  Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria , 2002, Journal of hypertension.

[5]  M. Mclaughlin,et al.  Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.

[6]  D. Salant,et al.  Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. , 2002, American journal of physiology. Renal physiology.

[7]  Kevin V Lemley,et al.  Podocytopenia and disease severity in IgA nephropathy. , 2002, Kidney international.

[8]  Mi-kyung Kim,et al.  Expression of nephrin in acquired human glomerular disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  D. Kerjaschki.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. , 2001, The Journal of clinical investigation.

[10]  M. Saleem,et al.  Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. , 2001, The Journal of clinical investigation.

[11]  I. Tikkanen,et al.  Changes in the Expression of Nephrin Gene and Protein in Experimental Diabetic Nephropathy , 2001, Laboratory Investigation.

[12]  H. Baelde,et al.  Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies. , 2001, Kidney international.

[13]  M. Farquhar,et al.  Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. , 2001, The Journal of clinical investigation.

[14]  T. Graf,et al.  Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin , 2001, The Journal of experimental medicine.

[15]  M. Cooper,et al.  Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension , 2001, Diabetologia.

[16]  A. Brun,et al.  Frontal Dysfunction and Frontal Cortical Synapse Loss in Alcoholism –The Main Cause of Alcohol Dementia? , 2001, Dementia and Geriatric Cognitive Disorders.

[17]  G. Ghiggeri,et al.  Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  G. Camussi,et al.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. , 2001, The American journal of pathology.

[19]  K. Tryggvason,et al.  Expression of nephrin in pediatric kidney diseases. , 2001, Journal of the American Society of Nephrology : JASN.

[20]  H. Holthöfer,et al.  Alternatively Spliced Nephrin in Experimental Glomerular Disease of the Rat , 2000, Pediatric Research.

[21]  I. Tikkanen,et al.  Nephrin in experimental glomerular disease. , 2000, Kidney international.

[22]  J. van den Born,et al.  Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. , 2000, Kidney international.

[23]  D. Salant,et al.  Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. , 2000, Kidney international.

[24]  H. Baelde,et al.  Processing renal biopsies for diagnostic mRNA quantification: improvement of RNA extraction and storage conditions. , 2000, Journal of the American Society of Nephrology : JASN.

[25]  J. van den Born,et al.  Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. , 2000, The American journal of pathology.

[26]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.

[27]  S. Somlo,et al.  Getting a foothold in nephrotic syndrome , 2000, Nature Genetics.

[28]  D. Salant,et al.  Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. , 1999, The Journal of clinical investigation.

[29]  K. Tryggvason,et al.  Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. , 1999, Journal of the American Society of Nephrology : JASN.

[30]  Michael Loran Dustin,et al.  Congenital nephrotic syndrome in mice lacking CD2-associated protein. , 1999, Science.

[31]  J. Pringle,et al.  Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[33]  D. Kerjaschki,et al.  Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes. , 1998, Journal of the American Society of Nephrology : JASN.

[34]  N. Gretz,et al.  Progression of glomerular diseases: is the podocyte the culprit? , 1998, Kidney international.

[35]  E. Ritz,et al.  The Nephrotic Syndrome , 1998 .

[36]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[37]  P. Mundel,et al.  Regulation of podocyte structure during the development of nephrotic syndrome , 1998, Journal of Molecular Medicine.

[38]  M. Welsh,et al.  Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome. , 1997, The American journal of physiology.

[39]  T. Oite,et al.  Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. , 1988, Journal of immunology.

[40]  D. Kerjaschki,et al.  Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell , 1984, The Journal of cell biology.

[41]  M. Farquhar.  Editorial: The primary glomerular filtration barrier--basement membrane or epithelial slits? , 1975, Kidney international.

[42]  M. Karnovsky,et al.  The isoporous substructure of the human glomerular slit diaphragm. , 1975, Kidney international.

[43]  M. Karnovsky,et al.  POROUS SUBSTRUCTURE OF THE GLOMERULAR SLIT DIAPHRAGM IN THE RAT AND MOUSE , 1974, The Journal of cell biology.

[44]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[45]  P Vivien,et al.  [The nephrotic syndrome]. , 1965, Le Progres medical.

[46]  D. Manley.  The nephrotic syndrome. II. , 1953, Arizona medicine.

[47]  R. Østerby,et al.  Glomerular epithelial foot processes in normal man and rats , 2004, Cell and Tissue Research.

[48]  U. Berg,et al.  Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  M. Rastaldi,et al.  Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases. , 2002, Kidney international.

[50]  O. Gribouval,et al.  Podocin localizes in the kidney to the slit diaphragm area. , 2002, The American journal of pathology.

[51]  T. Srivastava,et al.  Synaptopodin expression in idiopathic nephrotic syndrome of childhood. , 2001, Kidney international.

[52]  H. Kowalski,et al.  Podoplanin, a novel 43-kDa membrane protein, controls the shape of podocytes. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  T. Meyer,et al.  Morphometric analysis of effects of angiotensin II on glomerular structure in rats. , 1995, The American journal of physiology.